Alcoholic liver disease: Clinical and translational research

Manuela G. Neuman, Stephen Malnick, Yaakov Maor, Radu M. Nanau, Ehud Melzer, Peter Ferenci, Helmut K. Seitz, Sebastian Mueller, Haim Mell, Didier Samuel, Lawrence B. Cohen, Kusum Kharbanda, Natalia A Osna, Murali Ganesan, Kyle J. Thompson, Iain H. McKillop, Abraham Bautista, Ramon Bataller, Samuel W. French

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

The present review spans a broad spectrum of topics dealing with alcoholic liver disease (ALD), including clinical research, translational research, pathogenesis and therapies. A special accent is placed on alcohol misuse, as alcohol is a legally commercialized and taxable product. Drinking alcohol, particularly from a young age, is a major health problem. Alcoholism is known to contribute to morbidity and mortality. A systematic literature search was performed in order to obtain updated data (2008-2015). The review is focused on genetic polymorphisms of alcohol metabolizing enzymes and the role of cytochrome p450 2E1 and iron in ALD. Alcohol-mediated hepatocarcinogenesis is also discussed in the presence or absence of co-morbidities such as viral hepatitis C as well as therapeutic the role of innate immunity in ALD-HCV. Moreover, emphasis was placed on alcohol and drug interactions, as well as liver transplantation for end-stage ALD. Finally, the time came to eradicate alcohol-induced liver and intestinal damage by using betaine.

Original languageEnglish (US)
Pages (from-to)596-610
Number of pages15
JournalExperimental and Molecular Pathology
Volume99
Issue number3
DOIs
StatePublished - Dec 1 2015

Fingerprint

Alcoholic Liver Diseases
Translational Medical Research
Liver
Alcohols
Morbidity
Cytochrome P-450 CYP2E1
Betaine
Sodium Glutamate
Drug interactions
End Stage Liver Disease
Genetic Polymorphisms
Hepatitis C
Drug Interactions
Innate Immunity
Alcohol Drinking
Liver Transplantation
Alcoholism
Medical problems
Polymorphism
Iron

Keywords

  • Alcohol dehydrogenase
  • Alcoholic liver disease
  • Betaine
  • CYP2E1
  • Hepatitis B and C viral infection
  • Hepatocarcinogenesis
  • Human immunodeficiency virus
  • Liver fibrosis
  • Liver transplant

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Neuman, M. G., Malnick, S., Maor, Y., Nanau, R. M., Melzer, E., Ferenci, P., ... French, S. W. (2015). Alcoholic liver disease: Clinical and translational research. Experimental and Molecular Pathology, 99(3), 596-610. https://doi.org/10.1016/j.yexmp.2015.09.001

Alcoholic liver disease : Clinical and translational research. / Neuman, Manuela G.; Malnick, Stephen; Maor, Yaakov; Nanau, Radu M.; Melzer, Ehud; Ferenci, Peter; Seitz, Helmut K.; Mueller, Sebastian; Mell, Haim; Samuel, Didier; Cohen, Lawrence B.; Kharbanda, Kusum; Osna, Natalia A; Ganesan, Murali; Thompson, Kyle J.; McKillop, Iain H.; Bautista, Abraham; Bataller, Ramon; French, Samuel W.

In: Experimental and Molecular Pathology, Vol. 99, No. 3, 01.12.2015, p. 596-610.

Research output: Contribution to journalReview article

Neuman, MG, Malnick, S, Maor, Y, Nanau, RM, Melzer, E, Ferenci, P, Seitz, HK, Mueller, S, Mell, H, Samuel, D, Cohen, LB, Kharbanda, K, Osna, NA, Ganesan, M, Thompson, KJ, McKillop, IH, Bautista, A, Bataller, R & French, SW 2015, 'Alcoholic liver disease: Clinical and translational research', Experimental and Molecular Pathology, vol. 99, no. 3, pp. 596-610. https://doi.org/10.1016/j.yexmp.2015.09.001
Neuman MG, Malnick S, Maor Y, Nanau RM, Melzer E, Ferenci P et al. Alcoholic liver disease: Clinical and translational research. Experimental and Molecular Pathology. 2015 Dec 1;99(3):596-610. https://doi.org/10.1016/j.yexmp.2015.09.001
Neuman, Manuela G. ; Malnick, Stephen ; Maor, Yaakov ; Nanau, Radu M. ; Melzer, Ehud ; Ferenci, Peter ; Seitz, Helmut K. ; Mueller, Sebastian ; Mell, Haim ; Samuel, Didier ; Cohen, Lawrence B. ; Kharbanda, Kusum ; Osna, Natalia A ; Ganesan, Murali ; Thompson, Kyle J. ; McKillop, Iain H. ; Bautista, Abraham ; Bataller, Ramon ; French, Samuel W. / Alcoholic liver disease : Clinical and translational research. In: Experimental and Molecular Pathology. 2015 ; Vol. 99, No. 3. pp. 596-610.
@article{fe541aa8a72e4ac6997035c349ec9150,
title = "Alcoholic liver disease: Clinical and translational research",
abstract = "The present review spans a broad spectrum of topics dealing with alcoholic liver disease (ALD), including clinical research, translational research, pathogenesis and therapies. A special accent is placed on alcohol misuse, as alcohol is a legally commercialized and taxable product. Drinking alcohol, particularly from a young age, is a major health problem. Alcoholism is known to contribute to morbidity and mortality. A systematic literature search was performed in order to obtain updated data (2008-2015). The review is focused on genetic polymorphisms of alcohol metabolizing enzymes and the role of cytochrome p450 2E1 and iron in ALD. Alcohol-mediated hepatocarcinogenesis is also discussed in the presence or absence of co-morbidities such as viral hepatitis C as well as therapeutic the role of innate immunity in ALD-HCV. Moreover, emphasis was placed on alcohol and drug interactions, as well as liver transplantation for end-stage ALD. Finally, the time came to eradicate alcohol-induced liver and intestinal damage by using betaine.",
keywords = "Alcohol dehydrogenase, Alcoholic liver disease, Betaine, CYP2E1, Hepatitis B and C viral infection, Hepatocarcinogenesis, Human immunodeficiency virus, Liver fibrosis, Liver transplant",
author = "Neuman, {Manuela G.} and Stephen Malnick and Yaakov Maor and Nanau, {Radu M.} and Ehud Melzer and Peter Ferenci and Seitz, {Helmut K.} and Sebastian Mueller and Haim Mell and Didier Samuel and Cohen, {Lawrence B.} and Kusum Kharbanda and Osna, {Natalia A} and Murali Ganesan and Thompson, {Kyle J.} and McKillop, {Iain H.} and Abraham Bautista and Ramon Bataller and French, {Samuel W.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.yexmp.2015.09.001",
language = "English (US)",
volume = "99",
pages = "596--610",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Alcoholic liver disease

T2 - Clinical and translational research

AU - Neuman, Manuela G.

AU - Malnick, Stephen

AU - Maor, Yaakov

AU - Nanau, Radu M.

AU - Melzer, Ehud

AU - Ferenci, Peter

AU - Seitz, Helmut K.

AU - Mueller, Sebastian

AU - Mell, Haim

AU - Samuel, Didier

AU - Cohen, Lawrence B.

AU - Kharbanda, Kusum

AU - Osna, Natalia A

AU - Ganesan, Murali

AU - Thompson, Kyle J.

AU - McKillop, Iain H.

AU - Bautista, Abraham

AU - Bataller, Ramon

AU - French, Samuel W.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - The present review spans a broad spectrum of topics dealing with alcoholic liver disease (ALD), including clinical research, translational research, pathogenesis and therapies. A special accent is placed on alcohol misuse, as alcohol is a legally commercialized and taxable product. Drinking alcohol, particularly from a young age, is a major health problem. Alcoholism is known to contribute to morbidity and mortality. A systematic literature search was performed in order to obtain updated data (2008-2015). The review is focused on genetic polymorphisms of alcohol metabolizing enzymes and the role of cytochrome p450 2E1 and iron in ALD. Alcohol-mediated hepatocarcinogenesis is also discussed in the presence or absence of co-morbidities such as viral hepatitis C as well as therapeutic the role of innate immunity in ALD-HCV. Moreover, emphasis was placed on alcohol and drug interactions, as well as liver transplantation for end-stage ALD. Finally, the time came to eradicate alcohol-induced liver and intestinal damage by using betaine.

AB - The present review spans a broad spectrum of topics dealing with alcoholic liver disease (ALD), including clinical research, translational research, pathogenesis and therapies. A special accent is placed on alcohol misuse, as alcohol is a legally commercialized and taxable product. Drinking alcohol, particularly from a young age, is a major health problem. Alcoholism is known to contribute to morbidity and mortality. A systematic literature search was performed in order to obtain updated data (2008-2015). The review is focused on genetic polymorphisms of alcohol metabolizing enzymes and the role of cytochrome p450 2E1 and iron in ALD. Alcohol-mediated hepatocarcinogenesis is also discussed in the presence or absence of co-morbidities such as viral hepatitis C as well as therapeutic the role of innate immunity in ALD-HCV. Moreover, emphasis was placed on alcohol and drug interactions, as well as liver transplantation for end-stage ALD. Finally, the time came to eradicate alcohol-induced liver and intestinal damage by using betaine.

KW - Alcohol dehydrogenase

KW - Alcoholic liver disease

KW - Betaine

KW - CYP2E1

KW - Hepatitis B and C viral infection

KW - Hepatocarcinogenesis

KW - Human immunodeficiency virus

KW - Liver fibrosis

KW - Liver transplant

UR - http://www.scopus.com/inward/record.url?scp=84945963291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945963291&partnerID=8YFLogxK

U2 - 10.1016/j.yexmp.2015.09.001

DO - 10.1016/j.yexmp.2015.09.001

M3 - Review article

C2 - 26342547

AN - SCOPUS:84945963291

VL - 99

SP - 596

EP - 610

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 3

ER -